Content by Ludwig Cancer Research
|3 min read
Tumor Monocyte Content May Better Predict ICI Therapy Outcomes
Patients with high TMC may generate more proinflammatory immune cells, and therefore, respond better to immunotherapy
|3 min read
Building a Safer CAR-T Therapy
A new study addresses a central conundrum of CAR-T therapies: their tendency to provoke potentially deadly runaway immune responses against healthy tissues in patientsPage 1 of 1
